Dr. Avigan on BCMA-Targeted CAR T-Cell Therapy in Multiple Myeloma
October 11th 2019David E. Avigan, MD, professor of medicine, Harvard Medical School, and active staff, Hematology-Oncology, Beth Israel Deaconess Medical Center, discusses BCMA-targeted CAR T-cell therapy in multiple myeloma.
Read More